Atlanta’s winter social calendar quietly revolves around a handful of charitable black-tie nights and this year the Countdown for a Cure Foundation’s annual gala again positioned itself among them. The organization hosted its 2026 Evening of Energy on February 7 at The St. Regis Atlanta, bringing together physicians, donors, business leaders and philanthropic regulars for a cause rooted in science rather than spectacle.
The foundation, founded by Mitzi and Jeff Solomon after their family experienced mitochondrial disease firsthand, focuses on accelerating research into mitochondrial dysfunction — a cellular energy disorder linked not only to rare genetic conditions but also to broader illnesses such as neurodegeneration, metabolic disease and aging-related conditions.
The evening followed the traditional format of Atlanta charity society: cocktail reception, seated dinner, live and silent auctions, and an after-party.
But the tone leaned more scientific symposium than party circuit. Speakers emphasized that mitochondrial disorders affect roughly 1 in 4,000 individuals and remain widely underdiagnosed — a statistic that framed the night’s urgency.
Guests moved between conversations about research funding and personal stories from families impacted by the disease — a deliberate mix the organization uses to turn donors into long-term advocates rather than one-time contributors. The foundation positions mitochondrial medicine as a “root cause” field capable of influencing treatment across multiple conditions, which explains why its supporters range beyond traditional rare-disease philanthropy circles.
Where the money goes
Unlike awareness-only charities, Countdown for a Cure funds clinical research directly. The organization has already provided grants supporting mitochondrial biomarker development intended to help diagnose disease earlier and evaluate treatments more effectively.
That positioning tangible science outcomesis why the gala markets itself less as a benefit and more as an investment in medical advancement.
Atlanta hosts dozens of galas each year, but few center on emerging medical science. The Evening of Energy reflects a shift in philanthropy: donors increasingly want measurable progress rather than symbolic alignment. Instead of simply underwriting hospital programs, supporters are backing specific research pathways with defined clinical impact.
For attendees, the evening functioned as both social gathering and progress report — a reminder that modern charity culture is moving closer to venture funding than traditional fundraising. The tuxedos remain, but the language is becoming technical: biomarkers, clinical trials, translational medicine.
And that may be the reason the event keeps growing it offers not just visibility, but participation in discovery.
